EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: Analysis of data from the phase 3 FLEX study

1. Pirker, R.
2. Pereira, J.R.
3. Von Pawel, J.
4. Krzakowski, M.
5. Ramlau, R.
6. Park, K.
7. De Marinis, F.
8. Eberhardt, W.E.E.
9. Paz-Ares, L.
10. Störkel, S.
11. Schumacher, K.-M.
12. Von Heydebreck, A.
13. Celik, I.
14. O'Byrne, K.J.